Hologic, Inc. (Nasdaq:HOLX)
February 23rd, 2019
With markets going up Hologic, Inc. closed Friday up 1.10%, a $0.51 increase to close on $46.96. Furthermore it hit a new 52 week high of $47.12. Be aware that the Altman Z-Score1 (An indicator of the probability for a 2-year bankruptcy) is below the recommended threshold of 1.8%, and calculated to be 1.54.
Hologic, Inc. is listed on the S&P 500 index, and was one of 382 stocks that rose today. Weighted by market cap, HOLX represents about 0.05% of the S&P 500.
Hologic, Inc. is listed on NASDAQ 100, and was one of 86 stocks that rose today. Weighted by market cap, HOLX represents about 0.05% of NASDAQ 100.
Expectations from 16 analysts suggest that Hologic, Inc. might grow somewhat (1.85%), while Finbox has calculated (with medium uncertainty) a fair value price of $50.33.
The market sectors were mixed Saturday with a majority of the sectors trending up. Information Technology saw the biggest increase of the day (1.29%), while Consumer Staples saw the biggest drop (-0.28%). Industrials has seen the biggest year-to-date gain at 18.03%.
Consumer Staples and Financials both saw turn arounds from their five day positive performance, Consumer Staples with a drop of -0.28%.
- Information Technology went up with a 1.29% change.
- Communication Services went up with a 1.05% change.
- Healthcare went up with a 0.93% change.
- Industrials went up with a 0.64% change.
- Utilities went up with a 0.61% change.
- Real Estate went up with a 0.59% change.
- Consumer Discretionary went up with a 0.58% change.
- Materials went up with a 0.41% change.
- Energy went up with a 0.33% change.
- Financials went down with a -0.23% change.
- Consumer Staples went down with a -0.28% change.
Hologic, Inc. Info
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. The company offers Aptima molecular diagnostic assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and analytics products, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, and breast biopsy and biopsy site markers, as well as localization, specimen radiology, ultrasound, and connectivity solutions. In addition, the company offers Selenia Dimensions and 3Dimensions gantries for performing 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D software products; SecurView Workstations; computer aided detection systems; and stereotactic breast biopsy systems. Further, it provides SculpSure, PicoSure, and MonaLisa Touch aesthetic treatment systems; TempSure, a radio frequency energy sourced platform; and MedLite and other products, and system components for medical aesthetics. Additionally, the company offers NovaSure, an endometrial ablation system to treat women suffering from abnormal uterine bleeding; MyoSure surgical products for removal of fibroids, and uterine polyps and other pathology; and Horizon DXA System and Fluoroscan Insight FD skeletal health products. It sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts.
All amounts in USD unless otherwise indicated
(1) The Altman Z-Score calculation was first published in 1968 by Edward I. Altman, and is used for predicting the probability that a firm will go into bankruptcy within two years. An Altman Z-Score below 1.8 (Remember that Hologic, Inc.’s score is 1.54) is the trigger to be alert for this situation. Some analysts believe this score is less relevant for some companies, in particular companies operating to accumulate users that may run at huge losses to scale up.
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.